Tolerability of a recombinant DNA hepatitis B vaccine--results of post-marketing surveillance.
Singh
S
S
Department of Clinical and Medical Research, Panacea Biotech Ltd., New Delhi.
Sharma
D R
DR
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D017325:Hepatitis B Vaccines / Q000009:adverse effects*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011358:Product Surveillance, Postmarketing; D014614:Vaccines, Synthetic / Q000009:adverse effects*
D017325:Hepatitis B Vaccines; D014614:Vaccines, Synthetic